Press enter to begin your search

RenalytixAI - Company Overview

RENX
Thu, 11 Apr 2019, 14:00 BST

Dr. John Quackenbush, Dr. Steve Coca and Rahul Patel discuss artificial intelligence, its use and how it's progressing in medicine as well as the RenalytixAI approach with their lead product KidneyIntelX.

Rahul Patel
Executive Vice President, Digital Product and Services, Persistent Systems
RENX
Dr. Steve Coca
Associate Professor, Medicine, Nephrology; Associate Chair for Clinical and Translational Research, Icahn School of Medicine at Mount Sinai
RENX
Dr. John Quackenbush
Professor, Biostatistics, Harvard T.H. Chan School Of Public Health, Professor, Biostatistics and Computational Biology, Dana-Farber Cancer Institute, member of the RenalytixAI Scientific Advisory Board
RENX
5c927acfa2edb452af38731a
SHOW MORE
FROM THIS COMPANY
RenalytixAI - Company Overview
RENX Thu, 11 Apr 2019, 14:00 BST

Renalytix is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally.

Industry: Health Care

Contact:
Leman Street
https://renalytix.com/

Dr. John Quackenbush, Dr. Steve Coca and Rahul Patel discuss artificial intelligence, its use and how it's progressing in medicine as well as the RenalytixAI approach with their lead product KidneyIntelX.

Rahul Patel
Executive Vice President, Digital Product and Services, Persistent Systems
Dr. Steve Coca
Associate Professor, Medicine, Nephrology; Associate Chair for Clinical and Translational Research, Icahn School of Medicine at Mount Sinai
Dr. John Quackenbush
Professor, Biostatistics, Harvard T.H. Chan School Of Public Health, Professor, Biostatistics and Computational Biology, Dana-Farber Cancer Institute, member of the RenalytixAI Scientific Advisory Board
POWERED BY